List of patents in the Vaccine industry

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10071148 Immunotherapy against several tumors, such as lung cancer, including NSCLC	Patent 10071148 was granted and assigned to Immatics Biotechnologies on September, 2018 by the United States Patent and Trademark Office.		Immatics Biotechnologies	United States Patent and Trademark Office	10071148	September 11, 2018
‌ US Patent 7932826 System for tracking the location of components, assemblies, and subassemblies in an automated diagnostic analyzer	Patent 7932826 was granted and assigned to Abbott on April, 2011 by the United States Patent and Trademark Office.		Abbott	United States Patent and Trademark Office	7932826	April 26, 2011
‌ US Patent 10299924 System and method for implant delivery	Patent 10299924 was granted and assigned to Abbott on May, 2019 by the United States Patent and Trademark Office.	Abbott	Abbott	United States Patent and Trademark Office	10299924	May 28, 2019
‌ US Patent 8353829 Analyte monitoring device and methods of use	Patent 8353829 was granted and assigned to Abbott on January, 2013 by the United States Patent and Trademark Office.		Abbott	United States Patent and Trademark Office	8353829	January 15, 2013
‌ US Patent 7190988 Analyte monitoring device and methods of use	Patent 7190988 was granted and assigned to Abbott on March, 2007 by the United States Patent and Trademark Office.		Abbott	United States Patent and Trademark Office	7190988	March 13, 2007
‌ US Patent 10991190 Digital pass verification systems and methods	Patent 10991190 was granted and assigned to Abbott on April, 2021 by the United States Patent and Trademark Office.	Abbott	Abbott	United States Patent and Trademark Office	10991190	April 27, 2021
‌ US Patent 8081303 Method and apparatus for analyzing individual cells or particulates using fluorescent quenching and/or bleaching	Patent 8081303 was granted and assigned to Abbott on December, 2011 by the United States Patent and Trademark Office.		Abbott	United States Patent and Trademark Office	8081303	December 20, 2011
‌ US Patent 10369216 Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant	Patent 10369216 was granted and assigned to CureVac on August, 2019 by the United States Patent and Trademark Office.	CureVac	CureVac	United States Patent and Trademark Office	10369216	August 6, 2019
‌ US Patent 11110166 Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant	Patent 11110166 was granted and assigned to CureVac on September, 2021 by the United States Patent and Trademark Office.	CureVac	CureVac	United States Patent and Trademark Office	11110166	September 7, 2021
‌ US Patent 7043287 Method for modulating light penetration depth in tissue and diagnostic applications using same	Patent 7043287 was granted and assigned to Abbott on May, 2006 by the United States Patent and Trademark Office.		Abbott	United States Patent and Trademark Office	7043287	May 9, 2006
‌ US Patent 8937071 Compounds as rearranged during transfection (RET) inhibitors	Patent 8937071 was granted and assigned to GlaxoSmithKline on January, 2015 by the United States Patent and Trademark Office.	GlaxoSmithKline	GlaxoSmithKline	United States Patent and Trademark Office	8937071	January 20, 2015
‌ US Patent 11272867 Analyte monitoring device and methods of use	Patent 11272867 was granted and assigned to Abbott on March, 2022 by the United States Patent and Trademark Office.	Abbott	Abbott	United States Patent and Trademark Office	11272867	March 15, 2022
‌ US Patent 7699964 Membrane suitable for use in an analyte sensor, analyte sensor, and associated method	Patent 7699964 was granted and assigned to Abbott on April, 2010 by the United States Patent and Trademark Office.		Abbott	United States Patent and Trademark Office	7699964	April 20, 2010
‌ US Patent 7167734 Method for optical measurements of tissue to determine disease state or concentration of an analyte	Patent 7167734 was granted and assigned to Abbott on January, 2007 by the United States Patent and Trademark Office.		Abbott	United States Patent and Trademark Office	7167734	January 23, 2007
‌ US Patent 11434274 Peptides and combination of peptides for use in immunotherapy against various tumors	Patent 11434274 was granted and assigned to Immatics Biotechnologies on September, 2022 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11434274	September 6, 2022
‌ US Patent 9035063 Compounds as rearranged during transfection (RET) inhibitors	Patent 9035063 was granted and assigned to GlaxoSmithKline on May, 2015 by the United States Patent and Trademark Office.	GlaxoSmithKline	GlaxoSmithKline	United States Patent and Trademark Office	9035063	May 19, 2015
‌ US Patent 7951599 Method and apparatus for determining the hematocrit of a blood sample utilizing the intrinsic pigmentation of hemoglobin contained within the red blood cells	Patent 7951599 was granted and assigned to Abbott on May, 2011 by the United States Patent and Trademark Office.		Abbott	United States Patent and Trademark Office	7951599	May 31, 2011
‌ US Patent 8343092 Method and system for providing integrated medication infusion and analyte monitoring system	Patent 8343092 was granted and assigned to Abbott on January, 2013 by the United States Patent and Trademark Office.		Abbott	United States Patent and Trademark Office	8343092	January 1, 2013
‌ US Patent 11399748 Analyte monitoring device and methods of use	Patent 11399748 was granted and assigned to Abbott on August, 2022 by the United States Patent and Trademark Office.	Abbott	Abbott	United States Patent and Trademark Office	11399748	August 2, 2022
‌ US Patent 8945177 Gripper pusher mechanism for tissue apposition systems	Patent 8945177 was granted and assigned to Abbott on February, 2015 by the United States Patent and Trademark Office.		Abbott	United States Patent and Trademark Office	8945177	February 3, 2015
‌ US Patent 9789100 Compounds as rearranged during transfection (RET) inhibitors	Patent 9789100 was granted and assigned to GlaxoSmithKline on October, 2017 by the United States Patent and Trademark Office.	GlaxoSmithKline	GlaxoSmithKline	United States Patent and Trademark Office	9789100	October 17, 2017
‌ US Patent 8133738 Method and apparatus for determining the hematocrit of a blood sample utilizing the intrinsic pigmentation of hemoglobin contained within the red blood cells	Patent 8133738 was granted and assigned to Abbott on March, 2012 by the United States Patent and Trademark Office.		Abbott	United States Patent and Trademark Office	8133738	March 13, 2012
‌ US Patent 11400058 Intravenous formulations of coenzyme Q10 (CoQ10) and methods of use thereof	Patent 11400058 was granted and assigned to Berg on August, 2022 by the United States Patent and Trademark Office.		Berg	United States Patent and Trademark Office	11400058	August 2, 2022
‌ US Patent 8968746 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation	Patent 8968746 was granted and assigned to CureVac on March, 2015 by the United States Patent and Trademark Office.		CureVac	United States Patent and Trademark Office	8968746	March 3, 2015
‌ US Patent 11391747 Cartridge device with fluidic junctions for coagulation assays in fluid samples		Abbott	Abbott	United States Patent and Trademark Office	11391747	July 19, 2022

...

Results per page:

6,219 results

0 selected

6,219 results

0 selected